Savvy Updates, 11/1/21: No Drug Price Restraints for 2022, Sonoma Bio & T-Regs, Interoception: How the Brain Senses, New BioTech IPOs, Amazing Med-Tech Entrepreneur
Drug price restraints dropped as Biden prioritizes other measures was reported by Jonathan Bardner for BioPharmaDive.com, 29 October 2021. Industry opposition appears to have toppled another administration’s effort to lower prices. No matter what your...
Savvy Interesting Science, 10/29/21: Light-Emitting Plants, Sexier Technology
MIT Wants to Replace Lights With Glowing Plants was reported by Loukia Papadopoulos for InterestingEngineering.com, 10 October 2021. The light-emitting plants can be recharged in as little as ten seconds. HEY, could we fill our homes and offices with...
Savvy Tech and Research, 10/27/21: Dexcom & Garmin, Diabetes Research Connection on the FDA Process and Research Projects
See Your Dexcom G6 Data on Your Garmin Watch was reported by Andrew Briskin for diaTribe.org, 25 October 2021. In the era of continuous glucose monitors and smart devices, one of the key challenges in diabetes technology has been improving the way devices...
Savvy Updates, 10/25/21: Vertex Reduced Insulin by 91%, Pig to Human Kidney Transplant, Medtronic/Triple Jump Patch Pump, Dexcom ONE, Skin-Sweat Glucose Sensor, DreaMed AI Insulin Dosing Platform, OTC Hearing Aids
STEM-CELL THERAPY FOR TYPE 1 DIABETES REDUCED PATIENT’S INSULIN NEEDS BY 91% was written by Ginger Vieira for BeyondType1.org, 21 October 2021. The first patient dosed with VX-880 — a stem cell-derived potential therapy to treat Type 1 diabetes — has...
Savvy Looping, 10/22/21: So Cool, Diabeloop … plus Roche and others!
There’s a new closed-loop system out there (kind of like a new gunslinger in town!)! We/Loop and Learn were privileged to attend a Zoom event, hosted for us and several European influencers hosted on the occasion of the European congress EASD (European...
More Diabetes Blogs